St. Jude Medical Announces Increase in Quarterly Dividend
February 20 2015 - 02:43PM
Business Wire
Board of Directors declares 7 percent increase in quarterly
dividend
St. Jude Medical, Inc. (NYSE:STJ), a global medical device
company, today announced that its board of directors declared a 7
percent increase in the company’s quarterly dividend to $0.29 per
common share. The dividend is payable April 30, 2015, to
shareholders of record on March 31, 2015. At the new rate, the
annual dividend would be $1.16 per share, compared to the previous
annual dividend of $1.08 per share.
About St. Jude Medical
St. Jude Medical is a global medical device manufacturer
dedicated to transforming the treatment of some of the world’s most
expensive epidemic diseases. The company does this by developing
cost-effective medical technologies that save and improve lives of
patients around the world. Headquartered in St. Paul, Minn., St.
Jude Medical has four major clinical focus areas that include
cardiac rhythm management, atrial fibrillation, cardiovascular and
neuromodulation. For more information, please visit sjm.com or
follow us on Twitter @SJM_Media.
Forward-Looking Statements
This news release contains forward-looking statements within the
meaning of the Private Securities Litigation Reform Act of 1995
that involve risks and uncertainties. Such forward-looking
statements include the expectations, plans and prospects for the
Company, including potential clinical successes, anticipated
regulatory approvals and future product launches, and projected
revenues, margins, earnings and market shares. The statements made
by the Company are based upon management’s current expectations and
are subject to certain risks and uncertainties that could cause
actual results to differ materially from those described in the
forward-looking statements. These risks and uncertainties include
market conditions and other factors beyond the Company’s control
and the risk factors and other cautionary statements described in
the Company’s filings with the SEC, including those described in
the Risk Factors and Cautionary Statements sections of the
Company’s Annual Report on Form 10-K for the fiscal year ended
December 28, 2013 and Quarterly Report on Form 10-Q for the fiscal
quarter ended September 27, 2014. The Company does not intend to
update these statements and undertakes no duty to any person to
provide any such update under any circumstance.
St. Jude Medical, Inc.J.C. Weigelt, 651-756-4347Investor
Relationsjweigelt@sjm.com
SJM (NYSE:STJ)
Historical Stock Chart
From Feb 2024 to Mar 2024
SJM (NYSE:STJ)
Historical Stock Chart
From Mar 2023 to Mar 2024